Viatris Signs Exclusive Licensing Deal with Lexicon for Sotagliflozin Outside U.S. and Europe PITTSBURGH, Oct. 16, 2024 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) has reached an exclusive licensing agreement with Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to market sotagliflozin in all…
Sanofi and Orano Partner to Develop Next-Generation Radioligand Therapies Paris, October 17, 2024 – Sanofi and Orano Med, a subsidiary of the Orano Group and a leader in targeted alpha therapies for oncology, have announced a partnership to combine their…
ExSight Ventures Leads $30 Million Financing Round to Propel Development of the Polaris System for Eye Surgery Horizon Surgical Systems, a pioneering company specializing in micro-robotics for eye surgery, has successfully closed a $30 million Series A financing round. This…
Innovative Lab Services LLC Expands Reach with MLS Technologies Acquisition Innovative Lab Services LLC (ILS), a prominent provider of analytical instrumentation solutions, has announced its acquisition of MLS Technologies, Inc. (MLS), a leading analytical instrument services and support company. This…
Exscientia Reaches Key Milestones in Two Programs Under Sanofi Collaboration Exscientia has achieved significant progress in two discovery programs under its collaboration with Sanofi, earning $15 million in milestone payments. These programs have advanced to the core optimization phase, meeting…
At Lenovo Tech World, Lenovo™, in collaboration with Innovations in Dementia, launched “Alzheimer’s Intelligence,” a photorealistic 3D avatar powered by AI, designed to support individuals and families affected by dementia and Alzheimer’s. This innovative project offers a 24-hour conversational avatar…
MEDiC Life Sciences, a biotech startup based in Silicon Valley, has announced a new research collaboration with Hanmi Pharmaceutical, a prominent biopharmaceutical company in Korea. The partnership aims to identify cancer biomarkers for one of Hanmi’s clinical programs using MEDiC’s…
Eli Lilly and Company (NYSE: LLY) announced a significant $4.5 billion investment to establish the Lilly Medicine Foundry, a state-of-the-art facility for advanced manufacturing and drug development. This innovative center will enable Lilly to explore new methods for medicine production…
The global antibody drug market was valued at $218.6 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 11.2%, reaching $412.1 billion by 2029. This growth is fueled by an increase in product…
Phare Bio, in collaboration with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard’s Wyss Institute, has secured up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), part of the U.S.…
Takeda (TOKYO:4502/NYSE: TAK) has announced a commitment of JPY 4.6 billion (approximately USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners. This investment is part of Takeda’s ongoing efforts to bolster health system resilience in low- and…
Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) announced that Ascendis Pharma Bone Diseases A/S, a wholly-owned subsidiary of Ascendis Pharma A/S, has entered into a $150 million capped synthetic royalty funding agreement with Royalty Pharma, based…
